Brevan Howard Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Buy
15,987
+10,092
+171% +$1.14M 0.01% 650
2025
Q4
$739K Sell
5,895
-797
-12% -$102K 0.01% 909
2025
Q3
$896K Sell
6,692
-39,083
-85% -$5.13M ﹤0.01% 954
2025
Q2
$6.23M Sell
45,775
-6,865
-13% -$905K 0.04% 296
2025
Q1
$6.98M Buy
+52,640
New +$6.7M 0.07% 91
2024
Q4
Sell
-28,573
Closed -$3.26M 999
2024
Q3
$3.26M Sell
28,573
-2,602
-8% -$285K 0.02% 178
2024
Q2
$3.24M Buy
+31,175
New +$3.31M 0.03% 134
2024
Q1
Sell
-7,089
Closed -$780K 964
2023
Q4
$780K Buy
+7,089
New +$708K 0.01% 313

Other funds holding ABT

Brevan Howard Capital Management's ABT Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Abbott (ABT) stake by 171% in Q1 2026, buying an estimated $1.14M and bringing the position to 15,987 shares worth $1.64M. The position accounts for 0.01% of the portfolio, ranked #650.

Brevan Howard Capital Management first reported a position in ABT in Q4 2023 and has held it in 8 quarters since. The position peaked at $6.98M in Q1 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Brevan Howard Capital Management held 15,987 shares of Abbott worth $1.64M as of Q1 2026.
  • Brevan Howard Capital Management bought 10,092 Abbott shares in Q1 2026, an estimated $1.14M.
  • Abbott made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #650 holding.
  • Brevan Howard Capital Management first reported a position in Abbott in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Abbott position peaked at $6.98M in Q1 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.